Floatz logo

Etoposide

Large B-Cell Lymphoma

University of California, DavisSmall moleculePhase 2/3Active
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
89/ 100

Competitive context

70 Active assets in the Large B-Cell Lymphoma cohort.

Asset / SponsorPhaseRating
Axicabtagene Ciloleucel
Zhejiang Cancer Hospital
Phase 4BB
Cyclophosphamide
M.D. Anderson Cancer Center
Phase 4BB
Fludarabine
M.D. Anderson Cancer Center
Phase 4BB
Prednisone
Ruijin Hospital
Phase 3BB
Adriamycin
Ruijin Hospital
Phase 3BB

View all 49 →

Same molecule, other indications

Etoposide is also rated in:

acute megakaryoblastic leukemiaDormant
BBB
Indicative · Phase 3
79 / 100
View asset →
acute monocytic leukemiaDormant
BBB
Indicative · Phase 3
79 / 100
View asset →
acute myeloblastic leukemia with maturationDormant
BBB
Indicative · Phase 3
79 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →